USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: TOLEROGENICS, INC.
City: CHICAGO
State: IL
Zip+4: 60606-
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $192,679.00 1

Award List:

Use of Bispecific Antibody for Treating Non-obese Diabetes

Award Year / Program / Phase: 2011 / STTR / Phase I
Agency: HHS
Research Institution: UNIVERSITY OF ILLINOIS AT CHICAGO
Principal Investigator: Bellur S. Prabhakar – 312-996-4945
Award Amount: $192,679.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Activation of mature T lymphocytes is a multi-step process requiring both Ag-specific triggering of the TCR complex and co-stimulation mediated through the CD28-CD80/CD86 pathway. CTLA-4 is a critical inhibitor of T cell activation as evidenced by the lethal… More